Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9097 - 9104 of 12089 results
The Second Circuit (Sort of) and the Fourth Circuit (Completely) Refuse to Apply “Manager Rule” to Title VII Retaliation Claims
September 25, 2015| Blog| Viewpoint
VAWA Implementation and the Potential Impact of Proposed Massachusetts Bill S.650 on Colleges and Universities
September 25, 2015| Blog| Viewpoint
October Visa Bulletin Revised: New EB-2 India and China Filing Dates Retrogress
September 25, 2015| Blog| Viewpoint
Hot Topics in Laboratory Compliance at AHLA’s Fraud and Compliance Forum
September 24, 2015| Blog| Viewpoint
USCIS Temporarily Suspends Adjudication of I-485s
September 24, 2015| Blog| Viewpoint
Terror and Corruption Prosecutor Leaves for Private Sector
September 24, 2015| News
Policy and Legal Implications of Implementing Renewable Energy at Scale (Part 1 of 6)
September 23, 2015| Blog| Viewpoint
ECJ Advocate General’s Opinion Points Towards Imminent End of Safe Harbor As We Know It
September 23, 2015| Alert| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|